News

1 to 9 of 48 results

Medivir files with FDA for Lipsovir approval

06-10-2008

Sweden's Medivir has submitted a New Drug Application to the US Food and Drug Administration for Lipsovir,…

CortenemaHydrocortisoneHydrocortisone Cream and Ointment 2.5%

Switzerland's Galderma in $420 million deal to acquire CollaGenex Pharma

03-03-2008

Swiss dermatological pharmaceutical specialty group Galderma Pharma says it has entered into a definitive…

CortenemaDoxycyclineHydrocortisoneHydrocortisone Cream and Ointment 2.5%Oracea

JADO reports positive Ph IIa trial with TF002

25-02-2008

Dresden, Germany-based JADO Technologies GmbH, a developer of RAFT intervention therapeutics, has announced…

CortenemaHydrocortisoneHydrocortisone Cream and Ointment 2.5%

Enrollment complete in Ph II/III DuoCort trial

17-12-2007

Helsingborg, Sweden-based DuoCort Pharma AB says that targeted enrollment is complete in a pivotal Phase…

CortenemaHydrocortisoneHydrocortisone Cream and Ointment 2.5%NystatinOral

Phoqus initiates Ph II NIH Chronocort study

10-09-2007

UK drug developer Phoqus has initiated a Phase II clinical trial at the US National Institutes of Health…

CortefCortenemaHydrocortisoneHydrocortisone Cream and Ointment 2.5%Hydrocortisone TabletPfizer

Phoqus files Chronocort IND in USA

06-08-2007

UK drug developer Phoqus says that it has filed an Investigational New Drug application with the US Food…

CortenemaHydrocortisoneHydrocortisone Cream and Ointment 2.5%

Auriga Labs launches Xyralid in USA

16-07-2007

Auriga Laboratories has launched Xyralid RC (lidocaine HCL 3%/hydrocortisone acetate 1%) rectal cream…

CortenemaHydrocortisoneHydrocortisone Cream and Ointment 2.5%LidocaineXylocaine

1 to 9 of 48 results

COMPANY SPOTLIGHT

Menarini

Back to top